// App-Quantinova.ai

871 : Experience with Continuous Infusion of Recombinant Porcine FVIII in Patients with Acquired Hemophilia a

Researchers

Presenter

  • Daniel Lindsay

Principal Investigators

  • Jerome M. Teitel

  • Michelle Sholzberg

Medical Centers

  • Oncology Clinical Research Group, St. Michaels Hospital, Toronto, ON, Canada

  • Division of Neurology, St. Michaels Hospital, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Division of Neurology, St. Michaels Hospital, Toronto, ON, Canada

  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada

  • Department of Laboratory Medicine and Pathology, Mount Sinai Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved